UNSPSC 51102841: Colistin/hydrocortisone/neomycin/thonzonium

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class OT250. This VA Drug Class (OT250) classifies this compound as belonging to the group ANTI-INFECTIVE/ANTI-INFLAMMATORY COMBINATIONS, TOPICAL OTIC.

UNSPSC 51102841 Colistin/hydrocortisone/neomycin/thonzonium is a Commodity code that in practice covers pharmaceutical products procured through state and local health agencies, though the recent opportunities in the source do not align with this code's nominal scope. The Illinois Department of Public Health's August 2026 piggyback contract through MMCAP Infuse procured antibiotic tablets (Doxycycline Hyclate and Ciprofloxacin Hydrochloride) rather than the combination ear/eye drops the code nominally describes, and Seminole County, Florida's June 2026 IFB sought Naloxone and drug deactivation systems—both materially different product lines. State and local health departments and county health agencies are the primary issuing bodies under related pharmaceutical commodity codes, typically executing purchases through cooperative purchasing vehicles such as MMCAP Infuse or direct IFB processes for emergency preparedness and community health initiatives.

Recent activity shows modest geographic spread across Florida and Illinois. The Illinois Department of Public Health awarded a $2,999,999.11 contract to Chartwell Rx LLC over 36 months (12 months initial plus two renewal years) through an IFB process with a September 11, 2026 response date, while Seminole County posted an IFB (IFB60459723LAS) on June 30, 2026 requiring 1,900 units of Naloxone and 800 drug deactivation systems annually with quarterly deliveries to Sanford, Florida. The significant gap between the code's stated scope and the actual products solicited suggests this code may see limited relevant activity, or state and local procurement offices are applying it inconsistently to pharmaceutical procurements outside its nominal product definition.